The first new treatment for asthma attacks in 50 years may be a “game-changer”, researchers say. Offering patients an injection is more effective than the current care of steroid tablets and ...

Ultimately, her research led to mast cell activation syndrome, or MCAS, a condition in which mast cells (a type of white ...

A new treatment for asthma and COPD attacks could revolutionise patient care, scientists say. An injection given during attacks is more effective than the current steroid tablet treatment, reducing ...

You’ll receive Dupixent as an injection under your skin ... Dupixent and Xolair are both used to treat certain forms of asthma in adults and some children. They each have other uses, too.

A medication used to treat asthma can now be used to help people ... The most common side effects of Xolair are injection site reactions and fever, but the FDA noted that the drug has also been ...

Researchers from the Annals of Allergy, Asthma & Immunology study conducted 60 interviews with ... For the food allergy indication, Xolair is dosed by weight, from 75 mg to 600 mg by subcutaneous ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

Caution should be exercised in patients with history of cancer, any allergy, asthma, infections ... Most Common- Injection site reaction, viral infections, upper respiratory tract infection ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%. The findings, published ...